Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study

Fig. 5

The simultaneous PROK1 expression in both plasma and primary cancer lesion strongly affected patient prognosis. A The PROK1-positive group showed poorer CRS than that of the negative group in all stages. B In stage II patients, there was no significant difference. C In stage III patients, the PROK1-positive group was strongly associated with a lower CRS than that of the negative patients

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us